CD8A and neoplasm: Studies using highly immunogenic tumor models capable of producing spontaneous antitumor T cell activity revealed that type I IFN is essential for regulating the capacity of CD8α+ DCs to prime CD8+ T cells and facilitate subsequent immune-mediated antitumor responses [42,43].